Cargando…
Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations
At the time of writing, more than 440 million confirmed coronavirus disease 2019 (COVID-19) cases and more than 5.97 million COVID-19 deaths worldwide have been reported by the World Health Organization since the start of the outbreak of the pandemic in Wuhan, China. During the COVID-19 pandemic, ma...
Autores principales: | Tsai, Ming-Shao, Shih, Wei-Tai, Yang, Yao-Hsu, Lin, Yu-Shih, Chang, Geng-He, Hsu, Cheng-Ming, Yeh, Reming-Albert, Shu, Li-Hsin, Cheng, Yu-Ching, Liu, Hung-Te, Wu, Yu-Huei, Wu, Yu-Heng, Shen, Rou-Chen, Wu, Ching-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906167/ https://www.ncbi.nlm.nih.gov/pubmed/35279013 http://dx.doi.org/10.1016/j.biopha.2022.112802 |
Ejemplares similares
-
GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2
por: Tsai, Ming-Shao, et al.
Publicado: (2021) -
The anti-SARS-CoV-2 effect and mechanism of Chiehyuan herbal oral protection solution
por: Wu, Ching-Yuan, et al.
Publicado: (2023) -
GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies
por: Wu, Ching-Yuan, et al.
Publicado: (2020) -
Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer Cells
por: Lin, Yu-Shih, et al.
Publicado: (2019) -
SARS‐CoV‐2 spike protein enhances MAP4K3/GLK‐induced ACE2 stability in COVID‐19
por: Chuang, Huai‐Chia, et al.
Publicado: (2022)